RankingsPricing
  1. US-listed companies
  2. REPLIGEN CORP
  3. Financials
  4. Research & development

REPLIGEN CORPRGEN

Market cap
$8.9B
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 31, 202443+1.12%
Dec 31, 202343-2.76%
Dec 31, 202244+28.19%
Dec 31, 202134+69.82%
Dec 31, 202020+3.76%
Dec 31, 201919+22.94%
Dec 31, 201816+82.44%
Dec 31, 20179+17.91%
Dec 31, 20167+28.14%
Dec 31, 20156+2.34%
Dec 31, 20146-23.59%
Dec 31, 20137-30.02%
Dec 31, 201210+10.86%
Dec 31, 20119

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)